Here it is: details on how to understand more personally your liver and its long, windy, circuitous path to continuous detoxification. I've taken the example of three genes coding for Phase 1 detoxification. Now that you've had the equivalent of mini-medical school on the liver from my previous post, I thought I'd offer a dessert you can eat on this cleanse: more data!
There's a great test offered by Genova that examines your genetic programming for how your liver behaves in its detox job: the DetoxiGenomic Profile. Several other labs offer this type of testing but I like the robust explanations that Genova (formerly Great Smokies Lab) provides.
Keep in mind that your genetic programming can be significantly influenced by your nutrition, lifestyle and environment. More details are available at many online sites, such as Gene Cards. Let me know if you find other good resources in the Comments section.
This test can be particularly helpful to folks who have adverse reactions to drugs, as this is commonly due to a decreased capacity for clearing drugs from the body. Problems with Phase 1 clearance causes toxic overload in the body. Increased clearance of Phase 1 but without increased clearance in Phase 2 can lead to the formation of toxic intermediates, and in some cases, the intermediates are more toxic than the original toxin. Oh, no! Better to be on top of this.
Phase 1 involves the following SNPs or polymorphisms in the genes your inherited from your parents. You have inherited one of three conditions:
- you inherited the perfect level of the enzyme (homozygous normal - the optimal genomic potential)
- you inherited one bad allele and one good allele (heterozygous, usually a 30-50% decrement or increase in enzyme activity)
- you inherited both bad alleles, one bad one from each parent (homozygous, usually with a 70-90% reduction or increase in the activity of that enzyme).
may be carcinogenic if not. CYP1A1 also activates many environmental xenobiotics to pro-carcinogenic intermediates.
A CYP1A1 polymorphism is associated with increased CYP1A1 enzyme activity. Whereas the polymorphism MspI variant has been associated with both decreased and increased risk (in smokers) of breast cancer, the I462V variant has been linked in several studies with increased risk of cancer, especially in smokers and women exposed to PCBs.
CYP1B1 - Important guy for the 4-hydroxylation of estrogen; that is, CYP1B1 takes your garden-variety estrogen and converts it to 4-hydroxyestrogen. 4-hydroxyestrogen is a potent estrogen that may, in turn, be oxidized to carcinogenic compounds. A polymorphism is associated with increased enzyme activity, therefore increased production of these potentially harmful metabolites.
This is a review of just 3 of the many gene polymorphisms that affect your ability to detoxify. Contact Genova if you're interested in ordering the test from your local doctor, or if you are a patient or cleanser in our Gottfried Center practice, call Mandy at 510.893.3907.
Happy cleansing - today is day 6. We start our anti-inflammatory shakes on day 8! As always, share questions, concerns, clarifications, corrections, additional info in the Comments section. Thank you!